Sign in

CIK 0001490978

  • Large accelerated filer

Schrodinger, Inc.

Sign in to watch
Ticker
SDGR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
954284541
Phone
+1 503-299-1150
Business address
1540 BROADWAY, 24TH FLOOR, NEW YORK, NY, 10036
  1. 4 Grant or award Chief Medical Officer acquired 12,500 shares (grant or award)
  2. 4 Grant or award SVP & Controller acquired 9,800 shares (grant or award)
  3. 4 Grant or award EVP, CTO & COO, Software acquired 12,500 shares (grant or award)
  4. 4 Grant or award EVP, CLO & CPO acquired 12,500 shares (grant or award)
  5. 4 Grant or award See Remarks acquired 12,500 shares (grant or award)
  6. 4 Planned sale EVP, CLO & CPO sold 3,902 shares at $28.00 ($109,256)
  7. 4 Planned sale See Remarks sold 1,225 shares at $25.99 ($31,838)
  8. 4 Planned sale EVP, CTO & COO, Software sold 985 shares at $24.43 ($24,064)
  9. 4 Planned sale SVP & Controller sold 859 shares at $24.43 ($20,985)
  10. 4 Planned sale EVP, CLO & CPO sold 828 shares at $24.43 ($20,228)
  11. 4 Planned sale Chief Medical Officer sold 1,531 shares at $17.78 ($27,226)
  12. 4 Grant or award Director acquired 5,000 shares (grant or award)
  13. 4 Grant or award Director acquired 5,000 shares (grant or award)
  14. 4 Grant or award Director acquired 5,000 shares (grant or award)
  15. 4 Grant or award Director acquired 5,000 shares (grant or award)
  16. 4 Grant or award Director acquired 5,000 shares (grant or award)
  17. 4 Grant or award Director acquired 5,000 shares (grant or award)
  18. 4 Grant or award Director acquired 5,000 shares (grant or award)
  19. 4 Grant or award Director acquired 5,000 shares (grant or award)
  20. 4 Derivatives Options or other derivatives

Page 4 of 17 · 326 filings